Development Level

Tbio 31 | 11,445
Tdark 30 | 6,588
Tclin 3 | 613
Tchem 2 | 1,598

IMPC Phenotype

increased mean corpuscular hem... 2 | 96
preweaning lethality, complete... 2 | 979
abnormal cranium morphology 1 | 36
abnormal embryo size 1 | 220
abnormal retina morphology 1 | 71
cardiovascular system phenotyp... 1 | 36
decreased blood urea nitrogen ... 1 | 51
decreased circulating serum al... 1 | 82
decreased fasted circulating g... 1 | 65
decreased heart rate variabili... 1 | 13
decreased mean corpuscular hem... 1 | 50
decreased mean corpuscular vol... 1 | 79
decreased spleen weight 1 | 10
embryonic lethality prior to o... 1 | 239
embryonic lethality prior to t... 1 | 278
enlarged kidney 1 | 14
hypoactivity 1 | 132
increased circulating alkaline... 1 | 122
increased circulating sodium l... 1 | 71
increased grip strength 1 | 41
increased leukocyte cell numbe... 1 | 47
increased neutrophil cell numb... 1 | 46
increased spleen weight 1 | 10
preweaning lethality, incomple... 1 | 499
short tibia 1 | 97

Disease

osteosarcoma 23 | 7,950
lung cancer 22 | 4,740
ovarian cancer 19 | 8,520
psoriasis 17 | 6,694
interstitial cystitis 16 | 2,312
ulcerative colitis 16 | 1,819
Carcinoma 15 | 11,493
glioblastoma 15 | 5,792
Astrocytoma, Pilocytic 14 | 3,081
lung carcinoma 14 | 2,843
invasive ductal carcinoma 13 | 2,951
tuberculosis 13 | 2,010
Breast cancer 12 | 3,578
non-small cell lung cancer 12 | 2,890
subependymal giant cell astrocytoma 12 | 2,287
medulloblastoma, large-cell 11 | 6,241
cutaneous lupus erythematosus 10 | 1,057
group 3 medulloblastoma 10 | 4,104
intraductal papillary-mucinous adenoma (IPMA) 10 | 2,955
malignant mesothelioma 10 | 3,232
periodontitis 10 | 293
adult high grade glioma 9 | 3,801
colon cancer 9 | 1,478
lung adenocarcinoma 9 | 2,716
Cancer 8 | 2,499
Multiple myeloma 8 | 1,332
chronic lymphosyte leukemia 8 | 204
Autosomal recessive predisposition 7 | 1,442
Schizophrenia 7 | 1,160
ependymoma 7 | 4,679
intraductal papillary-mucinous carcinoma (IPMC) 7 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 7 | 3,291
primary Sjogren syndrome 7 | 735
Liver Cirrhosis, Experimental 6 | 769
adrenocortical carcinoma 6 | 1,428
astrocytoma 6 | 1,146
atypical teratoid / rhabdoid tumor 6 | 5,112
pancreatic cancer 6 | 2,398
Alzheimer's disease 5 | 658
Amebiasis 5 | 21
Arthritis 5 | 290
Kidney cancer 5 | 2,613
Leukemia 5 | 104
acute myeloid leukemia 5 | 783
astrocytic glioma 5 | 2,597
diabetes mellitus 5 | 1,728
ductal carcinoma in situ 5 | 1,745
head and neck cancer and chronic obstructive pulmonary disease 5 | 239
Down syndrome 4 | 499
Duchenne muscular dystrophy 4 | 601
Isolated growth hormone deficiency 4 | 30
Kidney disease 4 | 430
Lymphoma 4 | 81
Rheumatoid arthritis 4 | 1,191
Vascular disease 4 | 319
gastric carcinoma 4 | 807
oligodendroglioma 4 | 2,850
pancreatic ductal adenocarcinoma liver metastasis 4 | 1,962
posterior fossa group A ependymoma 4 | 468
Amyotrophic lateral sclerosis 3 | 451
Chronic Lymphocytic Leukemia 3 | 262
Diarrhea 3 | 253
Familial hemophagocytic lymphohistiocytosis 1 3 | 11
Familial hemophagocytic lymphohistiocytosis 2 3 | 15
Fatigue 3 | 182
Immunologic Deficiency Syndromes 3 | 113
Increased susceptibility to bacterial infections 3 | 42
Kidney Failure, Chronic 3 | 46
Myositis 3 | 30
Pick disease 3 | 1,894
Prone to bacterial infection 3 | 42
Recurrent bacterial infection 3 | 42
Systemic lupus erythematosus 3 | 194
Thrombocytopenia 3 | 197
active ulcerative colitis 3 | 764
autosomal dominant Emery-Dreifuss muscular dystrophy 3 | 510
breast carcinoma 3 | 1,638
cystic fibrosis 3 | 1,696
dermatomyositis 3 | 966
esophageal adenocarcinoma 3 | 737
mucosa-associated lymphoid tissue lymphoma 3 | 484
nasopharyngeal carcinoma 3 | 1,058
primary pancreatic ductal adenocarcinoma 3 | 1,109
Anemia 2 | 365
Dermatitis 2 | 157
Endometriosis 2 | 540
Eye disease 2 | 62
Failure to gain weight 2 | 365
Hepatomegaly 2 | 285
Hypersensitivity reaction type II disease 2 | 253
Kidney Failure 2 | 111
Malaria 2 | 160
Melanoma 2 | 711
Multiple Sclerosis 2 | 540
Pediatric failure to thrive 2 | 365
Renal Insufficiency 2 | 90
Renal failure in adulthood 2 | 76
acute quadriplegic myopathy 2 | 1,158
pancreatic carcinoma 2 | 562
pediatric high grade glioma 2 | 1,064

Tissue

Blood and immune system 24 | 16,909
Digestive Tract 24 | 17,369
Endocrine System 24 | 18,159
Female tissues 24 | 17,400
Male tissues 24 | 17,142
Respiratory system 24 | 16,393
Skin and soft tissues 24 | 17,230
Urinary Tract 24 | 16,678
Cardiovascular System 23 | 15,192
Liver and Pancreas 23 | 16,750
Nervous System 23 | 16,725

Target Family

Non-IDG 62 | 12,091
Enzyme 3 | 4,145
Transporter 1 | 473

GO Process

phagocytosis, engulfment 66 | 66
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Immunoglobulin heavy variable 1-69D IGHV1-69D Tdark Non-IDG 0.00000 0
SH3 domain-binding protein 1 SH3BP1 Tbio Non-IDG 0.00000 168
Immunoglobulin lambda constant 1 IGLC1 Tbio Non-IDG -1.96217 230.7 0
Immunoglobulin heavy variable 3-49 IGHV3-49 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 1-45 IGHV1-45 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 3-15 IGHV3-15 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 2-26 IGHV2-26 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 3-74 IGHV3-74 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 3-43 IGHV3-43 Tdark Non-IDG 0.00000 0
Immunoglobulin heavy variable 3-72 IGHV3-72 Tdark Non-IDG 0.00000 0